PHT's eDiary System Selected by Agile Therapeutics for Phase III Trial
PHT Corporation announced its LogPad System has been selected by Agile Therapeutics for use
PHT Corporation, a provider of technologies used to collect patient-driven eData for clinical research, says that its LogPad® System has been selected by Agile Therapeutics for use in its SECURE Phase III trial for its investigational product candidate, Twirla®. Agile's Senior VP of Clinical Development noted it chose the LogPad System for its proven track record of data quality and security, and comfort and convenience for patients, as well as PHT's leadership, experience and excellent customer service.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
